Drugs / Protescal gel
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT04951869 | Apr → Oct 2017 | keloid | Universiti Kebangsaan Malaysia Medical Centre | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Protescal gel | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04951869 ↗ |
| Route | Topical | “Protescal gel (0.5 mL) was again applied over the subcutaneous tissue prior to skin closure in Protescal group” NCT04951869 ↗ |